Absolute Bioavailability

Absolute Bioavailability is a pharmacokinetic parameter defined as the fraction of an administered dose of a drug that reaches the systemic circulation unchanged after administration by a particular route, as determined by comparing its systemic exposure (e.g., area under the concentration–time curve) with that achieved after intravenous administration of the same dose.

144

Publications

7K

Citations

662

Authors

203

Institutions

Publications per year

2017–2026

7

Authors

662

  1. GL
    Graham Lappin

    Hexcel (United Kingdom), United Kingdom

    3 publications · 191 citations

    3

    h-index

  2. ME
    Mark E. Arnold

    Bristol-Myers Squibb (United States), United States

    3 publications · 124 citations

    3

    h-index

  3. IW
    I. Walter‐Sack

    Heidelberg University, Germany

    3 publications · 143 citations

    3

    h-index

  4. XX
    Xiaohui Xu

    Bristol-Myers Squibb (United States), United States

    3 publications · 124 citations

    3

    h-index

  5. LJ
    Lisa J. Christopher

    Bristol-Myers Squibb (United States), United States

    3 publications · 124 citations

    3

    h-index

1–5 of 662

Venues

  1. PubMed

    Repository · 20 publications · 649 citations

    14

    h-index

  2. The Journal of Clinical Pharmacology

    13 publications · 976 citations

    13

    h-index

  3. Journal of Pharmaceutical Sciences

    9 publications · 306 citations

    9

    h-index

  4. European Journal of Clinical Pharmacology

    8 publications · 608 citations

    8

    h-index

  5. Clinical Pharmacology in Drug Development

    CPDD · 5 publications · 136 citations

    6

    h-index

1–5